Key result
Transradial approach for left main PCI was associated with similar 1-year major adverse cardiovascular events compared to transfemoral approach.
Why the study?
While transradial access for PCI is steadily increasing, the frequency and efficacy of transradial access specifically for left main PCI remain less studied.
Does transradial access compared to transfemoral access improve procedural success and 1-year MACE in patients undergoing left main percutaneous coronary intervention?
Observational (n=4,004)
Yes
Does transradial access compared to transfemoral access improve procedural success and 1-year MACE in patients undergoing left main percutaneous coronary intervention?
Answers are grounded in this paper and cite their sources.
Transradial access for left main PCI is associated with similar procedural success and 1-year MACE compared to transfemoral access, supporting its increasing use.
OBJECTIVES: We aimed to compare clinical characteristics and procedural outcomes of left main percutaneous interventions (LM-PCI) by transradial (TRA) versus transfemoral (TFA) approach in the VA healthcare system. BACKGROUND: TRA for percutaneous coronary intervention (PCI) is steadily increasing. However, the frequency and efficacy of TRA for LM-PCI remain less studied. METHODS: All LM-PCIs performed in the VA healthcare system were identified for fiscal year 2008 through 2018. Patients' baseline characteristics and procedure-related variables were compared by access site. Both short- and long-term clinical outcomes were analyzed using propensity score matching. RESULTS: A total of 4004 LM-PCI were performed in the VA via either radial or femoral access from 2008 to 2018. Among these, 596 (14.9%) LM PCIs were performed via TRA. Use of TRA for LM-PCI increased from 2.2% to 31.5% over the study period. Propensity matched outcome analysis, comparing TRA versus TFA, showed a similar procedural success (98.4% for TRA vs. 97.8% for TFA; RR: 1.01 [0.98, 1.03]) and 1-year major adverse cardiovascular events (MACE) (25.9% for TRA vs. 26.8% TFA; RR: 0.96 [0.74, 1.25]). There were no statistically significant differences among secondary outcomes analyses including major bleeding. CONCLUSION: Use of TRA for LM-PCI has been steadily increasing in the VA healthcare system. These findings demonstrate similar procedural success and 1-year MACE across access strategies, suggesting an opportunity to continue increasing TRA use for LM-PCI.
No takes yet. Share an insight, caveat, or question.
Bhardwaj et al. (2021) conducted an observational in Left main percutaneous coronary intervention (n=4,004). Transradial approach (TRA) vs. Transfemoral approach (TFA) was evaluated on 1-year major adverse cardiovascular events (MACE) (RR 0.96, 95% CI 0.74, 1.25). Transradial approach for left main PCI was associated with similar 1-year major adverse cardiovascular events compared to transfemoral approach.
Synapse has enriched 10 related papers. Consider them for comparative context: